Although endometriosis is a common disease in women of reproductive age, urinary system endometriosis is an exceedingly rare disease that may cause important clinical problems. In this paper we discussed a 42-year-old woman who had urinary bladder endometriosis misdiagnosed as urinary bladder tumor in imaging modalities. The diagnosis of endometriosis was made by histopathological examination of the operative material after partial resection of the urinary bladder. Urinary bladder endometriosis causes nonspecific signs and symptoms in many patients. In female patients presenting with unexplained urinary symptoms the differential diagnosis should include urinary bladder endometriosis that may mimic urinary bladder cancer and lead to difficulties in making definitive preoperative diagnosis.
What's known on the subject? and What does the study add? Öz Amaç: Ürogenital örneklerden izole edilen Ureaplasma urealyticum suşlarının antibiyotiklere karşı duyarlılıklarının zaman içerisinde değişip değişmediğinin değerlendirilmesidir. Gereç ve Yöntem: Hastane kayıtları retrospektif olarak incelenerek 2008 ve 2013 yılları içerisinde ürogenital örneklerde U. urealyticum üreyen olgular belirlenmiştir. Ayrıca 2001 yılında tebliğ ettiğimiz olgular göz önünde bulundurularak zaman içerisindeki değişim incelenmiştir. Bulgular: U. urealyticum izole edilen 60 hastada tetrasiklin ve doksisikline karşı yüksek oranlarda duyarlılık gözlenmiştir. Ofloksasin ve siprofloksasine karşı direncin yüksek oranlarda olduğu gözlenmiştir. 2008 ve 2013 yılları karşılaştırıldığında antibiyotiklere karşı direnç oranlarında anlamlı bir farklılık gözlenmemiştir. 2001 yılı kayıtları 2008 ve 2013 yılları kayıtları ile karşılaştırıldığında ofloksasin ve siprofloksasine karşı direncin istatistiksel olarak anlamlı bir şekilde arttığı gözlenmiştir (p<0,0005). Sonuç: U. urealyticum suşları kinolonlara karşı yüksek oranda direnç göstermektedirler. Zaman içerisinde direnç gelişimi artmaktadır. Tetrasiklin ve doksisikline karşı duyarlılık yüksek oranlarda devam etmektedir. Kültür yapılamayan olgularda uygulanacak olan ampirik tedavide bu durumun göz önünde bulundurulması yararlı olacaktır.
To investigate the prevalence of anal incontinence and constipation in patients with urinary incontinence. Materials and Methods: Adult female patients who presented with the complaint of urinary incontinence were evaluated with anal incontinence and constipation assessment survey prepared on the basis of "the International Consultation on Incontinence Questionnaire-Short Form", "the Overactive Bladder 8-Question Awareness Tool" and "the Rome 3" criteria. Results: Two hundred female patients with urinary incontinence were evaluated. The patients were in the age group of 18-88 with the average age of 55.24±16.86 standard deviation. Stress incontinence was present in 19.5%, urge incontinence in 36% and mixed incontinence in 44.5% of the subjects. Seventy-seven percent of patients presented with flatal incontinence, 7.5% with fecal incontinence and 52.5% presented with constipation. There was no difference between subgroups created according to age groups and types of urinary incontinence in terms of frequency of gastrointestinal symptoms. The incidence of constipation was statistically significantly higher in patients presenting with findings of urinary incontinence for more than 1 year and in those with overactive bladder (p<0.01 and p<0.001, respectively). Conclusion: Flatal incontinence was found in 77%, fecal incontinence in 7.5% and constipation in 52.2% of female adult patients with urinary incontinence. The incidence of constipation was higher at the level of statistical significance in patients presenting with findings of urinary incontinence for more than 1 year and in those with overactive bladder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.